CIAM
PHIO icon

Caitong International Asset Management’s Phio Pharmaceuticals PHIO Stock Holding History

Caitong International Asset Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Buy
+3
New +$3 ﹤0.01% 2343

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Caitong International Asset Management's PHIO Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Phio Pharmaceuticals (PHIO) in Q1 2026: 3 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #2343 among its holdings.

24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Caitong International Asset Management held 3 shares of Phio Pharmaceuticals worth $4 as of Q1 2026.
  • Phio Pharmaceuticals was a new Caitong International Asset Management position in Q1 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2343 holding.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.